PFIZER INC Outstanding Bonds
Note series still outstanding, nearest maturity first. Terms are from each offering's final pricing term sheet on SEC EDGAR; a reopening of the same CUSIP adds to its principal. Interest per payment = principal × coupon ÷ payments per year. Outstanding = principal issued minus each filed exchange, tender, redemption or conversion; it is (m) where the retired amount was not filed. Interest per payment uses the outstanding principal.
- 3.000% Notes due 2026: Principal issued $1.75B; Outstanding $1.75B; Coupon 3.00%.
- 4.450% Notes due 2028: Principal issued $4.00B; Outstanding $4.00B; Coupon 4.45%.
- 2.625% Notes due 2030: Principal issued $1.25B; Outstanding $1.25B; Coupon 2.63%.
- 4.650% Notes due 2030: Principal issued $3.00B; Outstanding $3.00B; Coupon 4.65%.
| Notes | Principal issued | Outstanding | Coupon | Trade date | Issue / settlement date | Maturity date | Interest payment dates | Interest per payment | Annual coupon interest | Optional redemption | Retired | Priced |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.000% Notes due 2026 CUSIP 717081EA7 · US717081EA70 | $1.75B | $1.75B | 3.00% | 2016-11-21 | 2026-12-15 | Semi-annually: June 15, December 15 | $26.25M | $52.50M | Make-Whole: 15 bps in the case | 2016-11-15 | ||
| 4.450% Notes due 2028 CUSIP (m) | $4.00B | $4.00B | 4.45% | 2023-05-19 | 2028-05-19 | Semi-annually: May 19, November 19 30/360 | $89.00M | $178.00M | Make-Whole: The 2025 Notes will be redeemable, in whole or in part, at any time and from time to time, prior to May 19, | 2023-05-17 | ||
| 2.625% Notes due 2030 CUSIP 717081EW9 · US717081EW90 | $1.25B | $1.25B | 2.63% | 2030-04-01 | Semi-annually: April 1, October 1 Actual/360 | $16.41M | $32.81M | At par from 2030-01-01 | 2020-03-25 | |||
| 4.650% Notes due 2030 CUSIP (m) | $3.00B | $3.00B | 4.65% | 2023-05-19 | 2030-05-19 | Semi-annually: May 19, November 19 30/360 | $69.75M | $139.50M | Make-Whole: The 2025 Notes will be redeemable, in whole or in part, at any time and from time to time, prior to May 19, | 2023-05-17 | ||
| 1.700% Notes due 2030 CUSIP 717081EY5 · US717081EY56 | $1.00B | $1.00B | 1.70% | 2020-05-28 | 2030-05-28 | Semi-annually: May 28, November 28 | $8.50M | $17.00M | Make-Whole: 15 bps in the case | 2020-05-19 | ||
| 1.750% Notes due 2031 CUSIP 717081FB4 · US717081FB45 | $1.00B | $1.00B | 1.75% | 2031-08-18 | Semi-annually: February 18, August 18 | $8.75M | $17.50M | The notes will be redeemable, in whole or in part, at any time and from time to time prior to May 18, 2031 (three months | 2021-08-16 | |||
| 4.750% Notes due 2033 CUSIP (m) | $5.00B | $5.00B | 4.75% | 2023-05-19 | 2033-05-19 | Semi-annually: May 19, November 19 30/360 | $118.75M | $237.50M | Make-Whole: The 2025 Notes will be redeemable, in whole or in part, at any time and from time to time, prior to May 19, | 2023-05-17 | ||
| 4.000% Notes due 2036 CUSIP 717081EC3 · US717081EC37 | $1.00B | $1.00B | 4.00% | 2016-11-21 | 2036-12-15 | Semi-annually: June 15, December 15 | $20.00M | $40.00M | Make-Whole: 15 bps in the case | 2016-11-15 | ||
| 2.550% Notes due 2040 CUSIP 717081EZ2 · US717081EZ22 | $1.00B | $1.00B | 2.55% | 2020-05-28 | 2040-05-28 | Semi-annually: May 28, November 28 | $12.75M | $25.50M | Make-Whole: 20 bps in the case | 2020-05-19 | ||
| 5.110% Notes due 2043 CUSIP (m) | $3.00B | $3.00B | 5.11% | 2023-05-19 | 2043-05-19 | Semi-annually: May 19, November 19 30/360 | $76.65M | $153.30M | Make-Whole: The 2025 Notes will be redeemable, in whole or in part, at any time and from time to time, prior to May 19, | 2023-05-17 | ||
| 4.125% Notes due 2046 CUSIP 717081ED1 · US717081ED10 | $1.25B | $1.25B | 4.13% | 2016-11-21 | 2046-12-15 | Semi-annually: June 15, December 15 | $25.78M | $51.56M | Make-Whole: and 20 bps in the case | 2016-11-15 | ||
| 4.20% Notes due 2047 CUSIP (m) | $1.06B | $1.06B | 4.20% | 2017-02-24 | 2047-03-17 | Semi-annually: March 17, September 17 | $22.36M | $44.73M | Make-Whole: The Notes will be redeemable, in whole but not in part, on each March 17 on or after March 17, 2020 at a red | 2017-02-24 | ||
| 2.700% Notes due 2050 CUSIP 717081FA6 · US717081FA61 | $1.25B | $1.25B | 2.70% | 2020-05-28 | 2050-05-28 | Semi-annually: May 28, November 28 | $16.88M | $33.75M | Make-Whole: and 20 bps in the case | 2020-05-19 | ||
| 5.300% Notes due 2053 CUSIP (m) | $6.00B | $6.00B | 5.30% | 2023-05-19 | 2053-05-19 | Semi-annually: May 19, November 19 30/360 | $159.00M | $318.00M | Make-Whole: The 2025 Notes will be redeemable, in whole or in part, at any time and from time to time, prior to May 19, | 2023-05-17 | ||
| 5.340% Notes due 2063 CUSIP (m) | $4.00B | $4.00B | 5.34% | 2023-05-19 | 2063-05-19 | Semi-annually: May 19, November 19 30/360 | $106.80M | $213.60M | Make-Whole: The 2025 Notes will be redeemable, in whole or in part, at any time and from time to time, prior to May 19, | 2023-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |